dc.contributor.author | Paschalis, A | |
dc.contributor.author | Welti, J | |
dc.contributor.author | Neeb, AJ | |
dc.contributor.author | Yuan, W | |
dc.contributor.author | Figueiredo, I | |
dc.contributor.author | Pereira, R | |
dc.contributor.author | Ferreira, A | |
dc.contributor.author | Riisnaes, R | |
dc.contributor.author | Rodrigues, DN | |
dc.contributor.author | Jimenez-Vacas, JM | |
dc.contributor.author | Kim, S | |
dc.contributor.author | Uo, T | |
dc.contributor.author | Di Micco, P | |
dc.contributor.author | Tumber, A | |
dc.contributor.author | Islam, MS | |
dc.contributor.author | Moesser, MA | |
dc.contributor.author | Abboud, M | |
dc.contributor.author | Kawamura, A | |
dc.contributor.author | Gurel, B | |
dc.contributor.author | Christova, R | |
dc.contributor.author | Gil, VS | |
dc.contributor.author | Buroni, L | |
dc.contributor.author | Crespo, M | |
dc.contributor.author | Miranda, S | |
dc.contributor.author | Lambros, MB | |
dc.contributor.author | Carreira, S | |
dc.contributor.author | Tunariu, N | |
dc.contributor.author | Alimonti, A | |
dc.contributor.author | Al-Lazikani, B | |
dc.contributor.author | Schofield, CJ | |
dc.contributor.author | Plymate, SR | |
dc.contributor.author | Sharp, A | |
dc.contributor.author | de Bono, JS | |
dc.date.accessioned | 2021-04-07T13:50:44Z | |
dc.date.available | 2021-04-07T13:50:44Z | |
dc.date.issued | 2021-02-15 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000620166400029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | en_US |
dc.identifier.citation | CANCER RESEARCH, 2021, 81 (4), pp. 1087 - 1100 (14) | en_US |
dc.identifier.issn | 0008-5472 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4494 | |
dc.identifier.eissn | 1538-7445 | en_US |
dc.identifier.eissn | 1538-7445 | |
dc.identifier.doi | 10.1158/0008-5472.CAN-20-1807 | en_US |
dc.identifier.doi | 10.1158/0008-5472.CAN-20-1807 | |
dc.format.extent | 1087 - 1100 (14) | en_US |
dc.language | English | en_US |
dc.language.iso | eng | en_US |
dc.publisher | AMER ASSOC CANCER RESEARCH | en_US |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_US |
dc.subject | Science & Technology | en_US |
dc.subject | Life Sciences & Biomedicine | en_US |
dc.subject | Oncology | en_US |
dc.subject | ANDROGEN-RECEPTOR | en_US |
dc.subject | INCREASED SURVIVAL | en_US |
dc.subject | GENE | en_US |
dc.subject | PROTEIN | en_US |
dc.subject | PROGRESSION | en_US |
dc.subject | ABIRATERONE | en_US |
dc.subject | VALIDATION | en_US |
dc.subject | INHIBITORS | en_US |
dc.subject | INTERACTS | en_US |
dc.subject | ONTOLOGY | en_US |
dc.title | JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer | en_US |
dc.type | Journal Article | |
dcterms.dateAccepted | 2020-12-02 | |
rioxxterms.version | VoR | en_US |
rioxxterms.versionofrecord | 10.1158/0008-5472.CAN-20-1807 | en_US |
rioxxterms.licenseref.startdate | 2021-02-15 | |
dc.relation.isPartOf | CANCER RESEARCH | en_US |
pubs.issue | 4 | en_US |
pubs.notes | Not known | en_US |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR/Students | |
pubs.organisational-group | /ICR/Students/PhD and MPhil | |
pubs.organisational-group | /ICR/Students/PhD and MPhil/18/19 Starting Cohort | |
pubs.publication-status | Published | en_US |
pubs.volume | 81 | en_US |
pubs.embargo.terms | Not known | en_US |
icr.researchteam | Computational Biology and Chemogenomics | |
icr.researchteam | Cancer Biomarkers | |
icr.researchteam | Prostate Cancer Targeted Therapy Group | |
dc.contributor.icrauthor | Tunariu, Nina | en_US |
dc.contributor.icrauthor | De Bono, Johann | en_US |
dc.contributor.icrauthor | Al-Lazikani, Bissan | en_US |
dc.contributor.icrauthor | Carreira, Suzanne | en_US |
dc.contributor.icrauthor | Gil, Veronica | en_US |
dc.contributor.icrauthor | Miranda, Susana | en_US |